Eric Delbridge
InvestorGeneral Partner, Public Equity at Sofinnova Ventures
Find your path to Eric
Sign up to see every warm intro you have to Eric
- Paths you didn't know you had: your email and LinkedIn already hold routes to Eric. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Eric Delbridge is a General Partner at Sofinnova Ventures, where he leads development of the firm's BioEquities strategy focused on public investments in global therapeutics companies. He joined Sofinnova in 2016 after managing market neutral therapeutics and healthcare portfolios at Balyasny Asset Management, and was previously a Partner at Spring Point Capital (formerly Botti Brown Asset Management) and a healthcare investment banker at Lazard and Credit Suisse. He holds an M.D. from Northwestern University, an M.B.A. from The Wharton School, and a B.A. in Classics from Yale University.
Invests in
Biotech
Colleagues at Sofinnova Ventures
Frequently asked questions
- Who is Eric Delbridge?
- Eric Delbridge is a General Partner at Sofinnova Ventures, where he leads development of the firm's BioEquities strategy focused on public investments in global therapeutics companies. He joined Sofinnova in 2016 after managing market neutral therapeutics and healthcare portfolios at Balyasny Asset Management, and was previously a Partner at Spring Point Capital (formerly Botti Brown Asset Management) and a healthcare investment banker at Lazard and Credit Suisse. He holds an M.D. from Northwestern University, an M.B.A. from The Wharton School, and a B.A. in Classics from Yale University.
- Where does Eric Delbridge work?
- Eric Delbridge is General Partner, Public Equity at Sofinnova Ventures.
- What does Eric Delbridge invest in?
- Eric Delbridge invests in Biotech.
About this profile. Compiled from public sources — Sofinnova Ventures's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights







